These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32661175)

  • 1. Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations.
    Melnikov SV; Stevens DL; Fu X; Kwok HS; Zhang JT; Shen Y; Sabina J; Lee K; Lee H; Söll D
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17924-17931. PubMed ID: 32661175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The population genetics of collateral resistance and sensitivity.
    Ardell SM; Kryazhimskiy S
    Elife; 2021 Dec; 10():. PubMed ID: 34889185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance.
    Burmeister AR; Fortier A; Roush C; Lessing AJ; Bender RG; Barahman R; Grant R; Chan BK; Turner PE
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11207-11216. PubMed ID: 32424102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
    Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
    Elife; 2020 May; 9():. PubMed ID: 32423531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitness Tradeoffs of Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli.
    Basra P; Alsaadi A; Bernal-Astrain G; O'Sullivan ML; Hazlett B; Clarke LM; Schoenrock A; Pitre S; Wong A
    Genome Biol Evol; 2018 Feb; 10(2):667-679. PubMed ID: 29432584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiosyncratic variation in the fitness costs of tetracycline-resistance mutations in Escherichia coli.
    Card KJ; Jordan JA; Lenski RE
    Evolution; 2021 May; 75(5):1230-1238. PubMed ID: 33634468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial evolution of antibiotic hypersensitivity.
    Lázár V; Pal Singh G; Spohn R; Nagy I; Horváth B; Hrtyan M; Busa-Fekete R; Bogos B; Méhi O; Csörgő B; Pósfai G; Fekete G; Szappanos B; Kégl B; Papp B; Pál C
    Mol Syst Biol; 2013 Oct; 9():700. PubMed ID: 24169403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of antibiotic resistance depends on evolutionary history in Escherichia coli.
    Angst DC; Hall AR
    BMC Evol Biol; 2013 Aug; 13():163. PubMed ID: 23914906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
    J Antimicrob Chemother; 2017 Nov; 72(11):3016-3024. PubMed ID: 28962020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and evolutionary bases of within-patient genotypic and phenotypic diversity in Escherichia coli extraintestinal infections.
    Levert M; Zamfir O; Clermont O; Bouvet O; Lespinats S; Hipeaux MC; Branger C; Picard B; Saint-Ruf C; Norel F; Balliau T; Zivy M; Le Nagard H; Cruveiller S; Chane-Woon-Ming B; Nilsson S; Gudelj I; Phan K; Ferenci T; Tenaillon O; Denamur E
    PLoS Pathog; 2010 Sep; 6(9):e1001125. PubMed ID: 20941353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
    Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
    Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitness trade-offs of multidrug efflux pumps in
    Liu Y; Van Horn AM; Pham MTN; Dinh BNN; Chen R; Raphael SDR; Paulino A; Thaker K; Somadder A; Frost DJ; Menke CC; Slimak ZC; Slonczewski JL
    Appl Environ Microbiol; 2024 Feb; 90(2):e0209623. PubMed ID: 38289137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly Contingent Phenotypes of Lon Protease Deficiency in Escherichia coli upon Antibiotic Challenge.
    Matange N
    J Bacteriol; 2020 Jan; 202(3):. PubMed ID: 31740490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene Amplification Uncovers Large Previously Unrecognized Cryptic Antibiotic Resistance Potential in E. coli.
    Suarez SA; Martiny AC
    Microbiol Spectr; 2021 Dec; 9(3):e0028921. PubMed ID: 34756069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance Gene Carriage Predicts Growth of Natural and Clinical
    Allen RC; Angst DC; Hall AR
    Appl Environ Microbiol; 2019 Feb; 85(4):. PubMed ID: 30530714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant bacteria compensate for the epistasis between resistances.
    Moura de Sousa J; Balbontín R; Durão P; Gordo I
    PLoS Biol; 2017 Apr; 15(4):e2001741. PubMed ID: 28419091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli.
    Wood KB; Cluzel P
    BMC Syst Biol; 2012 May; 6():48. PubMed ID: 22631053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary action of mutations reveals antimicrobial resistance genes in Escherichia coli.
    Marciano DC; Wang C; Hsu TK; Bourquard T; Atri B; Nehring RB; Abel NS; Bowling EA; Chen TJ; Lurie PD; Katsonis P; Rosenberg SM; Herman C; Lichtarge O
    Nat Commun; 2022 Jun; 13(1):3189. PubMed ID: 35680894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.